-
effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
January 03, 2012 - In this study,
the authors used past use to address indication,
by comparing current users to past … users” should resemble that of the “nonusers”;
if not, there is a possibility that confounding by
indication … Assessment
and control for confounding by indication
in observational studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
January 17, 2017 - We consider this study to be confounded by
indication.
2. … alone to
tonsillectomy alone or adenotonsillectomy as
those studies would likely be confounded by
indication … addressed
T in other pediatric conditions
Our Key Questions did not target sickle cell
disease as an indication … The studies referenced included children with
recurrent throat infection as an indication for
tonsillectomy
-
effectivehealthcare.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
January 01, 2012 - In August 2011, NPS began
submitting data for a new drug application to FDA for the same indication … patient education could be necessary before this intervention would become widely diffused for this
indication … treating SBS.
61
In December
2011, NPS completed submission of a new drug application for the same indication … A decision was expected from FDA by December 30, 2012.
60
Teduglutide is not approved for any
indication
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
December 01, 2014 - for managing T2DM, has been used off label for treating obesity while the company
pursues a labeled indication … If priced similarly to the diabetes indication, this would provide 18, 3 mg doses—the daily
dose for … The proposed
indication includes patients with BMIs of at least 40 kg/m2 or greater than 35 kg/m2 with … Nonetheless, the
manufacturer is pursuing a labeled indication for treating overweight and obesity. … If pricing is similar for the obesity
indication, such a carton would provide 18 doses at the 3 mg
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
September 21, 2012 - Observational studies
are susceptible to confounding by indication,
ascertainment biases in exposure … As a
summary of propensity to receive a medication or
strength of indication, propensity score identifies
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
December 01, 2013 - care
for treating social dysfunction in ASDs, because of the absence of other medications for this
indication … potential disparity in use of intranasal oxytocin by more female patients (because an approved
indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
September 01, 2016 - Finally, the full team will consider if the final conclusions are
influenced by any indication of reporting
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1512.pdf
December 01, 2015 - The developer is conducting phase III trials with
AVP-786 and AVP-923 for this indication, and we continue
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - has been used off label for
treating obesity, even while it is in clinical trials for an obesity indication … The approved indication is “as an adjunct to a reduced-calorie diet and increased physical
activity … The approved indication is as “an adjunct to a reduced-calorie diet and
increased physical activity … Nonetheless, the manufacturer is pursuing a labeled indication for
treating overweight and obesity. … The
approved indication is as follows:
BELVIQ is indicated to be used along with a reduced-calorie
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - cluster RCT, clinical trial, cohort study, case-control study),
number of participants (study size indication … The domain reporting bias
differentiates between suspected bias (e.g., there is indication of publication … Frequency and impact of confounding by
indication and healthy vaccinee bias in observational studies … Tdap)
Children, adults,
pregnant women
New dosing (2nd dose in people 10-64
years of age); age indication
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-e-1_0.xlsx
January 01, 2020 - records corresponding to adults in cardiac arrest where resuscitation had been attempted
Exlcuded: no indication … Adult Mixed Paramedic Yes ETI Ground Included: all patients undergoing
endotracheal intubation for any indication … Included: adult patients in whom EMS providers attempted to insert a PTL or an ET airway regardless of the indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
April 01, 2010 - Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-d.xlsx
January 01, 2023 - No masking, but no indication of deviations due to trial context.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-measures-framework_research.pdf
April 01, 2010 - OUTLINE
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists health care p…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-framework_research.pdf
April 01, 2010 - OUTLINE
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists health care p…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-results-search-strategies-developed-with-without-text-mining-tools.pdf
March 01, 2021 - For
simple SR topics (i.e., single indication–single drug), TMT searches were slightly less sensitive … • Across “simple” review topics (i.e., single indication-single drug) TMTs yielded no
unique additional … /phrase and subject terms for a narrowly defined clinical topic (i.e., a
single drug for a single indication … For simple review topics (i.e., single indication-single drug) TMT searches resulted in
no unique relevant … program, which tend to be complex and multicomponent, as
compared to simpler one intervention-one indication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
April 01, 2010 - Table 1
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists health ca…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - multiple sclerosis, while, in the United States, the therapy is used more widely.20, 21 Differences
in indication … A new indication for a product or a new product may be approved,
coverage decisions may be revised, … standards of care or treatment patterns (e.g., the introduction of a
new therapy, introduction of new indication
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
December 01, 2015 - indicated that
ES-4
off-label use of topiramate did not have potential for high impact for this indication … Prevention of
Hazardous Alcohol Use
Unmet need: Hazardous alcohol use is a composite substance abuse indication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
October 29, 2012 - The identification of an updating signal (qualitative or
quantitative) would be an indication that the … The identification of an updating signal (qualitative or quantitative) would
be an indication that the